$112.55
2.24[2.03%]
Last update: 11:15AM Get Real Time Here
Jazz Pharmaceuticals
(NASDAQ:JAZZ)Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Analyst Ratings, Price Targets, Predictions
Jazz Pharmaceuticals PLC has a consensus price target of $185.26, established from looking at the 67 latest analyst ratings. The last 3 analyst ratings were released from Needham, Cantor Fitzgerald, and JP Morgan on May 2, 2024, April 10, 2024, and March 22, 2024. With an average price target of $197.33 between Needham, Cantor Fitzgerald, and JP Morgan, there's an implied 83.57% upside for Jazz Pharmaceuticals PLC from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
Cantor Fitzgerald
JP Morgan
Truist Securities
Piper Sandler
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Jazz Pharmaceuticals
No data available to display
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|
FAQ
What is the target price for Jazz Pharmaceuticals (JAZZ)?
The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Needham on May 2, 2024. The analyst firm set a price target for $222.00 expecting JAZZ to rise to within 12 months (a possible 97.25% upside). 37 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Jazz Pharmaceuticals (JAZZ)?
The latest analyst rating for Jazz Pharmaceuticals (NASDAQ: JAZZ) was provided by Needham, and Jazz Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Jazz Pharmaceuticals (JAZZ)?
The last upgrade for Jazz Pharmaceuticals PLC happened on December 9, 2022 when Goldman Sachs raised their price target to $190. Goldman Sachs previously had a neutral for Jazz Pharmaceuticals PLC.
When was the last downgrade for Jazz Pharmaceuticals (JAZZ)?
The last downgrade for Jazz Pharmaceuticals PLC happened on November 27, 2023 when UBS changed their price target from $170 to $135 for Jazz Pharmaceuticals PLC.
When is the next analyst rating going to be posted or updated for Jazz Pharmaceuticals (JAZZ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Jazz Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Jazz Pharmaceuticals was filed on May 2, 2024 so you should expect the next rating to be made available sometime around May 2, 2025.
Is the Analyst Rating Jazz Pharmaceuticals (JAZZ) correct?
While ratings are subjective and will change, the latest Jazz Pharmaceuticals (JAZZ) rating was a reiterated with a price target of $0.00 to $222.00. The current price Jazz Pharmaceuticals (JAZZ) is trading at is $112.55, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.